Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases

被引:4
|
作者
Chen, Luxia [1 ]
Lei, Xuan [1 ]
Mahnke, Karsten [1 ]
机构
[1] Univ Hosp Heidelberg, Dept Dermatol, Neuenheimer Feld 440, D-69120 Heidelberg, Germany
关键词
adenosine receptors; inflammation; psoriasis; hyperplasia; immunosuppression; PLAQUE-TYPE PSORIASIS; ORAL CF101 DATA; MOUSE MODEL; KERATINOCYTE PROLIFERATION; INTERNATIONAL UNION; TOPICAL APPLICATION; A(2B) RECEPTORS; IL-6; PRODUCTION; GLUCOSE-UPTAKE; UP-REGULATION;
D O I
10.3390/ijms25115810
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inflammatory skin diseases highlight inflammation as a central driver of skin pathologies, involving a multiplicity of mediators and cell types, including immune and non-immune cells. Adenosine, a ubiquitous endogenous immune modulator, generated from adenosine triphosphate (ATP), acts via four G protein-coupled receptors (A1, A2A, A2B, and A3). Given the widespread expression of those receptors and their regulatory effects on multiple immune signaling pathways, targeting adenosine receptors emerges as a compelling strategy for anti-inflammatory intervention. Animal models of psoriasis, contact hypersensitivity (CHS), and other dermatitis have elucidated the involvement of adenosine receptors in the pathogenesis of these conditions. Targeting adenosine receptors is effective in attenuating inflammation and remodeling the epidermal structure, potentially showing synergistic effects with fewer adverse effects when combined with conventional therapies. What is noteworthy are the promising outcomes observed with A2A agonists in animal models and ongoing clinical trials investigating A3 agonists, underscoring a potential therapeutic approach for the management of inflammatory skin disorders.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases
    Bruce N. Cronstein
    Michail Sitkovsky
    Nature Reviews Rheumatology, 2017, 13 : 41 - 51
  • [2] Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases
    Cronstein, Bruce N.
    Sitkovsky, Michail
    NATURE REVIEWS RHEUMATOLOGY, 2017, 13 (01) : 41 - 51
  • [3] Targeting adenosine receptors to prevent inflammatory skin diseases
    Gessi, Stefania
    Merighi, Stefania
    Borea, Pier Andrea
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (08) : 553 - 554
  • [4] Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases
    Vass, G.
    Horvath, I.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (09) : 917 - 922
  • [5] Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases
    Hasko, Gyorgy
    Linden, Joel
    Cronstein, Bruce
    Pacher, Pal
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) : 759 - 770
  • [6] Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
    György Haskó
    Joel Linden
    Bruce Cronstein
    Pál Pacher
    Nature Reviews Drug Discovery, 2008, 7 : 759 - 770
  • [7] Diet in the Pathogenesis and Treatment of Inflammatory Bowel Diseases
    Lee, Dale
    Albenberg, Lindsey
    Compher, Charlene
    Baldassano, Robert
    Piccoli, David
    Lewis, James D.
    Wu, Gary D.
    GASTROENTEROLOGY, 2015, 148 (06) : 1087 - 1106
  • [8] Itraconazol in treatment of the inflammatory skin diseases
    Kazlouskaya, VV
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : A75 - A75
  • [9] Targeting adenosine receptors for the treatment of retinal degenerative diseases
    Ambrosio, Antonio F.
    PURINERGIC SIGNALLING, 2018, 14 : S31 - S31
  • [10] PROSTAGLANDIN SYNTHESIS BY SKIN AND ITS RELATIONSHIP TO INFLAMMATORY SKIN DISEASES
    KINGSTON, WP
    PRETTY, K
    GREAVES, MW
    BIORHEOLOGY, 1975, 12 (01) : 79 - 79